DOCSLIB.ORG

Dickkopf 4 (DKK4) Acts on Wnt&Sol;Β-Catenin

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dickkopf 4 (DKK4) Acts on Wnt&Sol;Β-Catenin Oncogene (2012) 31, 4233–4244 & 2012 Macmillan Publishers Limited All rights reserved 0950-9232/12 www.nature.com/onc ORIGINAL ARTICLE Dickkopf 4 (DKK4) acts on Wnt/b-catenin pathway by influencing b-catenin in hepatocellular carcinoma S Fatima1,7, NP Lee1,7, FH Tsang1, FT Kolligs2, IOL Ng3, RTP Poon1, ST Fan1 and JM Luk1,4,5,6 1Department of Surgery, The University of Hong Kong, Pokfulam, Hong Kong; 2Department of Medicine II, Klinikum Grosshadern, University of Munich, Marchioninistrasse, Munich, Germany; 3Department of Pathology, The University of Hong Kong, Pokfulam, Hong Kong; 4Department of Pharmacology and Department of Surgery, National University of Singapore, Singapore; 5Cancer Science Institute and Institute of Molecular and Cell Biology, Singapore and 6Department of Oncology, pRED China, Roche R&D Center, Shanghai, China Deregulation of Wnt/b-catenin pathway is a hallmark of Introduction major gastrointestinal cancers including hepatocellular carcinoma (HCC). The oncogenic role of b-catenin is well Liver cancer ranks as the second and sixth leading cause defined but reasons for its accumulation in HCC remain of cancer death worldwide in men and women, unclear. Dickkopf 4 (DKK4) acts as a negative regulator respectively, and hepatocellular carcinoma (HCC) of Wnt/b-catenin pathway but its functional role in liver accounts for 70–80% of total liver cancers (Jemal carcinogenesis has not been studied. We investigated the et al., 2011). HCC associates a dismal prognosis because role of DKK4 in b-catenin regulation in HCC. Reduced of late presentation of the disease and high risk of expression of DKK4 was found in 47% (38/81) of HCC, postoperative tumour recurrence (Hao et al., 2009). as measured by quantitative real time PCR. Ectopic Although the risk factors for HCC are well known expression of DKK4 in two HCC cell lines, PLC/PRF/5 (Kemp et al., 2005), the cellular and molecular mechan- (PLC) and MHCC97L (97L), attenuated b-catenin isms contributing to hepatocarcinogenesis are poorly responsive luciferase activity, and decreased both understood. The Wnt/b-catenin pathway is critical for b-catenin and cyclin D1 protein levels. To study the effect embryonic development, cell proliferation, survival, self- of DKK4 on cell growth and tumourigenicity, two stable renewal and regeneration (Gonzalez, 2006; Nejak-Bowen HCC cell lines were established from PLC and 97L cells. and Monga, 2011). However, its deregulation is a Functional assays demonstrated that overexpression of hallmark of several cancers including HCC (Inagawa DKK4 hampered cell proliferation, reduced colony et al., 2002). Surplus b-catenin in the cytoplasm is formation and retarded cell migration. When DKK4- phosphorylated by a multiprotein destruction complex expressing 97L stable cells were used to induce tumour consisting of glycogen synthase kinase 3b (GSK3b), Axin xenografts in nude mice (n ¼ 8), reduction in tumour sizes and adenomatous polyposis coli (APC). The phosphory- was observed (P ¼ 0.027). Furthermore, immunohisto- lated b-catenin is then ubiquitinated and degraded by the chemical studies showed that decreased expression of proteasome (Orford et al., 1997; MacDonald et al., DKK4 was associated with b-catenin accumulation in 2009). Upon binding of Wnt to one of the members of HCC tissues. Additionally, inhibition of the proteasome the frizzled family receptors and to the low-density using specific inhibitor in DKK4-expressing 97L stable lipoprotein-related protein-5 (LRP5) or LRP6 co-recep- cells masked the effect of b-catenin. Our findings suggest tors, the phosphorylation and degradation of b-catenin is a potential tumour suppressive role of DKK4 as well as inhibited, and it accumulates in the cytoplasm and that of an important regulator of HCC. translocates to the nucleus (Zeng et al., 2005). Inside the Oncogene (2012) 31, 4233–4244; doi:10.1038/onc.2011.580; nucleus, b-catenin forms a complex with T-cell factor published online 16 January 2012 (TCF)/lymphoid enhancer factor and upregulates target genes that are implicated in cancer development for Keywords: hepatocellular carcinoma; Wnt/b-catenin example, c-Myc and cyclin D1 (Logan and Nusse, 2004). signalling; DKK4; tumourigenesis Although Wnt/b-catenin signalling is frequently activated in HCC, reasons for its activation are not well understood. Somatic mutations of b-catenin have only been observed in 12–26% of HCC (de La Coste et al., 1998; Wong et al., 2001), but cytoplasmic and nuclear accumulation of b-catenin have been reported Correspondence. Current address: Professor JM Luk, Department of more commonly in 40–70% of HCC (Huang et al., 1999; Oncology, Roche R&D Center, pRED China, 720 Cai Lun Road, Wong et al., 2001). Mutations of other Wnt/b-catenin Shanghai 201203, China. signalling components like Axin1 and Axin2 have only E-mail: [email protected] been observed in 10% and 3% of HCC cases, 7These authors contributed equally to this work. Received 18 July 2011; revised 17 October 2011; accepted 9 November respectively (Taniguchi et al., 2002). Furthermore, 2011; published online 16 January 2012 inactivating mutations of APC are unlikely to contribute Action of DKK4 on Wnt/b-catenin pathway S Fatima et al 4234 significantly as they are very rare (Chen et al., 1998), frequent in HCC tissues compared with their matched implying that other undefined mechanisms may con- non-cancerous cirrhotic tissues, implying that methyla- tribute to Wnt/b-catenin activation in HCC. tion of DKK2 and DKK3 may not be an early event in The dickkopf (DKK) family is important for verte- HCC but may function in the progression of HCC brate development and comprises four secreted glyco- (Yang et al., 2010). Additionally, methylation of DKK3 proteins (DKK1, DKK2, DKK3 and DKK4) of has been significantly associated with short progression- 255–350 amino acids (Niehrs, 2006). They are classified free survival in HCC patients (Ding et al., 2009; Yang as inhibitors of Wnt/b-catenin signalling but members of et al., 2010). Although reduced expression of DKK4 has the DKK family exert different effects on Wnt/b-catenin only been reported in HCC cell lines (Maehata et al., signalling, and their mechanism of action has not been 2008), its function in hepatocarcinogenesis with respect fully delineated (Fatima et al., 2011). With the exception to the Wnt/b-catenin pathway has not been explored. of DKK3, whose receptor has not been identified, Therefore, in this study we investigated the functional DKK1, DKK2 and DKK4 compete with frizzled family role of DKK4 in HCC. receptors binding to the extracellular domain of LRP5/ LRP6 receptor complex in response to attenuation of Wnt activity (Krupnik et al., 1999; Semenov et al., 2001; Results Niehrs, 2006). DKK1, DKK2 and DKK4 also bind to Kremens, another class of transmembrane receptors Reduced expression of DKK4 in HCC cell lines (Mao et al., 2002; Mao and Niehrs, 2003; Nakamura and tissues and Matsumoto, 2008), although the exact mechanism Eight HCC cell lines were evaluated for DKK4 mRNA of how Krm-DKKs-LRP6 complex inhibit Wnt activity expression using quantitative PCR (qPCR) and com- has not been defined. DKK1 is an antagonist of the pared with immortalized normal hepatocytes MIHA. Wnt/b-catenin pathway and also a downstream target of Marked reduction of DKK4 was found in all HCC cell Wnt/b-catenin signalling (Niida et al., 2004; Chamorro lines (Figure 1a). To test whether the reduced expression et al., 2005; Gonzalez-Sancho et al., 2005). However, in of DKK4 in HCC cells is due to DNA methylation, HCC its negative feedback mechanism is abrogated and representative HCC cell lines, such as Hep3B, HuH-7, overexpression of DKK1 in HCC has been associated PLC/PRF/5 (PLC) and MHCC97L (97L), were treated with cytoplasmic and nuclear b-catenin accumulation with increasing concentrations of 5-azacytidine, a (Yu et al., 2009). DKK2 can serve as both an inhibitor pharmacological inhibitor of DNA methyltransferase and activator depending on cellular context (Mao et al., to rule out the effects of DNA methylation. Figure 1b 2001), and the role of DKK3 remains unclear. Previous illustrates unaltered DKK4 expression following treat- study suggested DKK3 to have no effect on Wnt/b- ment with 5-azacytidine, suggesting other reasons for its catenin signalling (Krupnik et al., 1999), whereas others reduced expression in HCC. We next checked the have demonstrated nuclear accumulation of b-catenin as expression of DKK4 in 81 matched pairs of HCC a result of reduced DKK3 expression in lung cancer tumours and their corresponding adjacent non-tumour (Yue et al., 2008). Furthermore, DKK2 and DKK3 are liver tissues of the same patient. DKK4 was reduced in both methylated in HCC and their methylation is more 47% (38/81) of HCC tumour tissues (Figure 1c). Figure 1 Reduced expression of DKK4 mRNA in HCC cell lines and tissues. qPCR was used to determine the mRNA expression of DKK4 in HCC cells and tissues. (a) Reduced expression of DKK4 mRNA was found in HCC cells (HepG2, Hep3B, HuH-7, PLC, H2P, H2M, 97L and 97H) when compared with immortalized normal hepatocytes MIHA. (b) This reduction observed in HCC cells was not associated with DNA methylation when representative HCC cells (Hep3B, HuH-7, PLC and 97L) were treated with increasing concentrations of 5-azacytidine and no effects on DKK4 mRNA expression were observed. (c) Reduced mRNA expression of DKK4 was found in tumour (T) tissues when compared with their adjacent non-tumour liver (NT) tissues in 81 patients with primary HCC. DKK4 expression of each sample is presented by the fold ratio against all NT tissues. *Po 0.05. Oncogene Action of DKK4 on Wnt/b-catenin pathway S Fatima et al 4235 Whereas DKK4-negative was defined as having a DKK4 suppresses in vivo tumourigenicity tumour/non-tumour expression ratio less than twofold, To further explore the in vivo tumour suppressive ability DKK4-positive had this ratio greater than twofold.
Load more

Recommended publications
  • Increased Liver Carcinogenesis and Enrichment of Stem Cell Properties in Livers of Dickkopf 2 (Dkk2) Deleted Mice
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 20 Increased liver carcinogenesis and enrichment of stem cell properties in livers of Dickkopf 2 (Dkk2) deleted mice Thorsten Maass1, Jens Marquardt2, Ju-Seog Lee3, Markus Krupp4, Peter Scholz-Kreisel2, Carolin Mogler5, Peter Schirmacher5, Martina Müller1, Heiner Westphal6, Peter R. Galle2, Andreas Teufel1 1Department of Internal Medicine I, University of Regensburg, Regensburg, Germany 2I. Department of Medicine, University Medical Center Mainz, Mainz, Germany 3Cancer Biology Program, MD Anderson Cancer Center, Houston, TX, USA 4Department of Informatics, Johannes Gutenberg University Mainz, Mainz, Germany 5Institute of Pathology, University of Heidelberg, Heidelberg, Germany 6 Laboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA Correspondence to: Andreas Teufel, email: [email protected] Keywords: transcriptomics profiling, prognostic signature, genetic signature, Dkk2, stem cells Received: January 13, 2015 Accepted: February 08, 2015 Published: March 16, 2015 ABSTRACT Dkk2 a antagonist of the Wnt/β-catenin-signaling pathway was shown to be silenced in diverse cancers. More recent data indicate that Dkk family members may also possess functions independent of Wnt-signaling during carcinogenesis. The detailed biological function of Dkks and its relevance for liver cancer is unknown. We analyzed the effects of a genetic deletion of Dkk2 (Dkk2−/−) in a hepatocarcinogenesis model using DEN/Phenobarbital. Untreated Dkk2−/− animals, showed considerable atypia with variation of hepatocyte size and chromatin density. In livers of Dkk2−/− mice nodule formation was seen at 9 months of age with focal loss of trabecular architecture and atypical hepatocytes and after DEN induction Dkk2−/− mice developed significantly more liver tumors compared to controls.
    [Show full text]
  • Dickkopf-3 Links HSF1 and YAP/TAZ Signalling to Control Aggressive Behaviours in Cancer-Associated fibroblasts
    ARTICLE https://doi.org/10.1038/s41467-018-07987-0 OPEN Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts Nicola Ferrari 1,8, Romana Ranftl1, Ievgeniia Chicherova1, Neil D. Slaven2, Emad Moeendarbary3,4, Aaron J. Farrugia1, Maxine Lam1, Maria Semiannikova1, Marie C. W. Westergaard5, Julia Tchou6, Luca Magnani 2 & Fernando Calvo1,7 1234567890():,; Aggressive behaviours of solid tumours are highly influenced by the tumour microenviron- ment. Multiple signalling pathways can affect the normal function of stromal fibroblasts in tumours, but how these events are coordinated to generate tumour-promoting cancer- associated fibroblasts (CAFs) is not well understood. Here we show that stromal expression of Dickkopf-3 (DKK3) is associated with aggressive breast, colorectal and ovarian cancers. We demonstrate that DKK3 is a HSF1 effector that modulates the pro-tumorigenic behaviour of CAFs in vitro and in vivo. DKK3 orchestrates a concomitant activation of β-catenin and YAP/TAZ. Whereas β-catenin is dispensable for CAF-mediated ECM remodelling, cancer cell growth and invasion, DKK3-driven YAP/TAZ activation is required to induce tumour- promoting phenotypes. Mechanistically, DKK3 in CAFs acts via canonical Wnt signalling by interfering with the negative regulator Kremen and increasing cell-surface levels of LRP6. This work reveals an unpredicted link between HSF1, Wnt signalling and YAP/TAZ relevant for the generation of tumour-promoting CAFs. 1 Tumour Microenvironment Team, Division of Cancer Biology, The Institute of Cancer Research, London SW3 6JB, UK. 2 Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK. 3 Department of Mechanical Engineering, University College London, London WC1E 7JE, UK.
    [Show full text]
  • Overexpression of Human Dickkopf-1, an Antagonist of Wingless/WNT
    0023-6837/03/8303-429$03.00/0 LABORATORY INVESTIGATION Vol. 83, No. 3, p. 429, 2003 Copyright © 2003 by The United States and Canadian Academy of Pathology, Inc. Printed in U.S.A. Overexpression of Human Dickkopf-1, an Antagonist of wingless/WNT Signaling, in Human Hepatoblastomas and Wilms’ Tumors Oliver Wirths, Anke Waha, Sascha Weggen, Peter Schirmacher, Thomas Kühne, Cynthia G. Goodyer, Steffen Albrecht, Dietrich von Schweinitz, and Torsten Pietsch Department of Neuropathology (OW, AW, SW, TP), University of Bonn Medical Center, Bonn, and Department of Pathology (PS), University of Cologne, Cologne, Germany; Departments of Pediatric Oncology (TK) and Pediatric Surgery (DvS), University of Basel, Basel, Switzerland; and Department of Endocrinology (CGG), McGill University, and Department of Pathology (SA), Sir Mortimer B. Davis Jewish General Hospital, Montreal, Canada SUMMARY: Hepatoblastomas (HBs) represent the most frequent malignant liver tumors of childhood; yet little is known about the molecular pathogenesis and the alterations in expression patterns of these tumors. We used a suppression subtractive hybridization approach to identify new candidate genes that may play a role in HB tumorigenesis. cDNA species derived from corresponding liver and fetal liver were subtracted from HB cDNAs, and a series of interesting candidates were isolated that were differentially expressed. One of the transcripts overexpressed in HB was derived from the human Dickkopf-1 (hDkk-1) gene, which encodes a secreted protein acting as a potent inhibitor of the wingless/WNT signaling pathway. We examined the hDkk-1 expression levels in 32 HB biopsy specimens and in the corresponding liver samples, in 4 HB cell lines, and in a panel of other tumors and normal tissues using a differential PCR approach and Northern blotting.
    [Show full text]
  • KREMEN1 Antibody (Pab)
    21.10.2014KREMEN1 antibody (pAb) Rabbit Anti-Human/Mouse/Rat Kringle-containing protein marking the eye and the nose (KRM1, Dickkopf receptor) Instruction Manual Catalog Number PK-AB718-7261 Synonyms KREMEN1 Antibody: Kringle-containing protein marking the eye and the nose, Kringle containing transmembrane protein 1, KRM1, Dickkopf receptor Description Kremen (Kringle containing protein marking the eye and the nose) proteins are type I transmembrane proteins that contain extracellular kringle, WSC and CUB domains and an intracellular region without any conserved motifs. Kremens bind a subset of the secreted Dickkopf proteins (Dkk 1, 2, and 4) with high affinity to modulate the canonical Wnt signaling pathway that is transduced by the ternary receptor complex composed of Wnt, Frizzled, and the LDL receptor related protein 5/6 (LRP5/6) coreceptor. KREMEN1 is a receptor for the Dickkopf protein which blocks Wnt/beta catenin signaling. It is necessary to ensure normal spatial and temporal patterns of Wnt activity during developmental processes. Quantity 100 µg Source / Host Rabbit Immunogen Rabbit polyclonal KREMEN1 antibody was raised against an 18 amino acid peptide near the carboxy terminus of human KREMEN1. Purification Method Affinity chromatography purified via peptide column. Clone / IgG Subtype Polyclonal antibody Species Reactivity Human, Mouse, Rat Specificity Three isoforms of KREMEN1 exists as a result of alternative splicing event. Formulation Antibody is supplied in PBS containing 0.02% sodium azide. Reconstitution During shipment, small volumes of antibody will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 μl or less, we recommend gently tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the container’s cap.
    [Show full text]
  • Expression of Secreted Wnt Antagonists in Gastrointestinal Tissues
    515 ORIGINAL ARTICLE J Clin Pathol: first published as 10.1136/jcp.2004.018598 on 27 April 2005. Downloaded from Expression of secreted Wnt antagonists in gastrointestinal tissues: potential role in stem cell homeostasis T Byun, M Karimi, J L Marsh, T Milovanovic, F Lin, R F Holcombe ............................................................................................................................... J Clin Pathol 2005;58:515–519. doi: 10.1136/jcp.2004.018598 Background: Wnt signalling dysregulation has been implicated in cancer, including colon and gastric cancer. Initiation of Wnt signalling is modulated by soluble Wnt antagonists (sWAs), including soluble frizzled related proteins, dickkopf (Dkk) proteins, and Wnt inhibitory factor-1 (Wif1). Aims: To evaluate the role of sWAs in upper (gastric) and lower (colon) gastrointestinal tract tumorigenesis. Methods: Dkk1–3, Wif1, and FrzB expression was evaluated by in situ RNA hybridisation on normal and See end of article for authors’ affiliations malignant human gastric and colon tissues. Expression was graded semiquantitatively. ....................... Results: Wif1, Dkk1, and Dkk2 were not expressed in normal gastric tissue. Dkk3 was expressed in some samples, with stronger expression in deep gastric glands. FrzB was expressed in several normal gastric Correspondence to: Dr R F Holcombe, MD, samples, but not in matched tumour specimens. In contrast, Dkk1 and FrzB were not expressed in normal Division of Hematology/ colon. Wif1 was expressed in most colon samples, with stronger expression at crypt bases. Dkk3 and Dkk2 Oncology, University of expression was also concentrated at crypt bases. There were no differences between sWA expression in California, Irvine Medical malignant colon and matched normal tissue. Center, 101 The City Drive, Bld 23, Rm 244, Conclusions: sWA expression differed between upper and lower gastrointestinal tract.
    [Show full text]
  • R-Spondin1 Regulates Wnt Signaling by Inhibiting Internalization of LRP6
    R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6 Minke E. Binnerts, Kyung-Ah Kim, Jessica M. Bright, Sejal M. Patel, Karolyn Tran, Mei Zhou, John M. Leung, Yi Liu, Woodrow E. Lomas III, Melissa Dixon, Sophie A. Hazell, Marie Wagle, Wen-Sheng Nie, Nenad Tomasevic, Jason Williams, Xiaoming Zhan, Michael D. Levy, Walter D. Funk, and Arie Abo* Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070-6211 Communicated by Lewis T. Williams, Five Prime Therapeutics, Inc., Emeryville, CA, March 13, 2007 (received for review December 1, 2006) The R-Spondin (RSpo) family of secreted proteins act as potent Wnt signaling by modulating levels of LRP6 on the cell surface, activators of the Wnt/␤-catenin signaling pathway. We have previ- through inhibition of DKK1-dependent internalization of LRP6. ously shown that RSpo proteins can induce proliferative effects on the gastrointestinal epithelium in mice. Here we provide a mechanism Results and Discussion whereby RSpo1 regulates cellular responsiveness to Wnt ligands by To further investigate the role of RSpo1 in the activation of the Wnt modulating the cell-surface levels of the coreceptor LRP6. We show pathway, we generated a HEK-293 stable cell line expressing a TCF that RSpo1 activity critically depends on the presence of canonical luciferase reporter plasmid. In agreement with reported results Wnt ligands and LRP6. Although RSpo1 does not directly activate (16), both RSpo1 and Wnt3A proteins induced a comparable LRP6, it interferes with DKK1/Kremen-mediated internalization of TCF-mediated reporter activity [supporting information (SI) Fig. LRP6 through an interaction with Kremen, resulting in increased LRP6 7].
    [Show full text]
  • R-Spondin1 Regulates Wnt Signaling by Inhibiting Internalization of LRP6
    R-Spondin1 regulates Wnt signaling by inhibiting internalization of LRP6 Minke E. Binnerts, Kyung-Ah Kim, Jessica M. Bright, Sejal M. Patel, Karolyn Tran, Mei Zhou, John M. Leung, Yi Liu, Woodrow E. Lomas III, Melissa Dixon, Sophie A. Hazell, Marie Wagle, Wen-Sheng Nie, Nenad Tomasevic, Jason Williams, Xiaoming Zhan, Michael D. Levy, Walter D. Funk, and Arie Abo* Nuvelo, Inc., 201 Industrial Road, Suite 310, San Carlos, CA 94070-6211 Communicated by Lewis T. Williams, Five Prime Therapeutics, Inc., Emeryville, CA, March 13, 2007 (received for review December 1, 2006) The R-Spondin (RSpo) family of secreted proteins act as potent Wnt signaling by modulating levels of LRP6 on the cell surface, activators of the Wnt/␤-catenin signaling pathway. We have previ- through inhibition of DKK1-dependent internalization of LRP6. ously shown that RSpo proteins can induce proliferative effects on the gastrointestinal epithelium in mice. Here we provide a mechanism Results and Discussion whereby RSpo1 regulates cellular responsiveness to Wnt ligands by To further investigate the role of RSpo1 in the activation of the Wnt modulating the cell-surface levels of the coreceptor LRP6. We show pathway, we generated a HEK-293 stable cell line expressing a TCF that RSpo1 activity critically depends on the presence of canonical luciferase reporter plasmid. In agreement with reported results Wnt ligands and LRP6. Although RSpo1 does not directly activate (16), both RSpo1 and Wnt3A proteins induced a comparable LRP6, it interferes with DKK1/Kremen-mediated internalization of TCF-mediated reporter activity [supporting information (SI) Fig. LRP6 through an interaction with Kremen, resulting in increased LRP6 7].
    [Show full text]
  • Expression of Cancer Stem Cell-Associated DKK1 Mrna
    ANTICANCER RESEARCH 37 : 4881-4888 (2017) doi:10.21873/anticanres.11897 Expression of Cancer Stem Cell-associated DKK1 mRNA Serves as Prognostic Marker for Hepatocellular Carcinoma TOMOHIKO SAKABE 1,2 , JUNYA AZUMI 1, YOSHIHISA UMEKITA 2, KAN TORIGUCHI 3, ETSURO HATANO 3, YASUAKI HIROOKA 4 and GOSHI SHIOTA 1 1Division of Molecular and Genetic Medicine, Department of Genetic Medicine and Regenerative Therapeutics, Graduate School of Medicine, Tottori University, Yonago, Japan; 2Division of Organ Pathology, Department of Pathology, Faculty of Medicine, Tottori University, Yonago, Japan; 3Department of Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 4Department of Pathobiological Science and Technology, School of Health Science, Faculty of Medicine, Tottori University, Yonago, Japan Abstract. Background/Aim: Cancer stem cells (CSCs) are Hepatocellular carcinoma (HCC) is the sixth most common associated with prognosis of hepatocellular carcinoma (HCC). cancer, and the third most frequent cause of death worldwide In our previous study, we created cDNA microarray databases (1). Since biomarkers are useful for early diagnosis and on the CSC population of human HuH7 cells. In the present prediction of prognosis (2), they may provide effective study, we identified genes that might serve as prognostic treatment options. Although several biomarkers, including markers of HCC by employing existing databases. Materials alpha-fetoprotein (AFP), protein induced by vitamin K and Methods: Expressions of glutathione S-transferase pi 1 deficiency or antagonist-II (PIVKAII), and glypican-3, were (GSTP1), lysozyme (LYZ), C-X-C motif chemokine ligand 5 reported as being useful (2, 3), identification of novel (CXCL5), interleukin-8 (IL8) and dickkopf WNT signaling biomarkers for HCC is expected to improve prognosis of pathway inhibitor 1 (DKK1), the five most highly expressed patients with HCC.
    [Show full text]
  • Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding To
    Developmental Cell Article Structural Basis of Wnt Signaling Inhibition byDickkopfBindingtoLRP5/6 Victoria E. Ahn,1 Matthew Ling-Hon Chu,1 Hee-Jung Choi,1 Denise Tran,1 Arie Abo,2 and William I. Weis1,* 1Departments of Structural Biology and Molecular & Cellular Physiology, Stanford University School of Medicine, Stanford, CA 94305, USA 2California Institute for Regenerative Medicine (CIRM), San Francisco, CA 94305, USA *Correspondence: [email protected] DOI 10.1016/j.devcel.2011.09.003 SUMMARY natal lethality with midbrain and hindbrain defects, posterior truncation, and abnormal limb development, whereas deletion LDL receptor-related proteins 5 and 6 (LRP5/6) are of LRP5 leads to osteoporosis and other metabolic defects coreceptors for Wnt growth factors, and also bind (Kato et al., 2002; Pinson et al., 2000). Missense mutations in Dkk proteins, secreted inhibitors of Wnt signaling. LRP5 associated with autosomal recessive osteoporosis-pseu- The LRP5/6 ectodomain contains four b-propeller/ doglioma syndrome (OPPG) compromise Wnt signaling (Gong EGF-like domain repeats. The first two repeats, et al., 2001). Missense mutations in the LRP5 ectodomain are LRP6(1-2), bind to several Wnt variants, whereas also associated with autosomal dominant and recessive familial exudative vitreoretinopathy (FEVR), although the biochemical LRP6(3-4) binds other Wnts. We present the crystal consequences of these changes have not been reported (Jiao structure of the Dkk1 C-terminal domain bound to et al., 2004; Qin et al., 2005; Toomes et al., 2004). LRP6(3-4), and show that the Dkk1 N-terminal The LRP5/6 ectodomain comprises four repeating units of domain binds to LRP6(1-2), demonstrating that a six-bladed b-propeller connected to an EGF-like domain, a single Dkk1 molecule can bind to both portions of followed by three LDLR-type A repeats (Figure 1A).
    [Show full text]
  • Methylation Patterns of DKK1, DKK3 and Gsk3p Are
    cancers Article Methylation Patterns of DKK1, DKK3 and GSK3b Are Accompanied with Different Expression Levels in Human Astrocytoma Anja Kafka 1,2,*, Anja Bukovac 1,2, Emilija Brglez 1, Ana-Marija Jarmek 1, Karolina Poljak 1, Petar Brlek 1, Kamelija Žarkovi´c 3,4, Niko Njiri´c 1,5 and Nives Pe´cina-Šlaus 1,2 1 Laboratory of Neuro-Oncology, Croatian Institute for Brain Research, School of Medicine, University of Zagreb, Šalata 12, 10 000 Zagreb, Croatia; [email protected] (A.B.); [email protected] (E.B.); [email protected] (A.-M.J.); [email protected] (K.P.); [email protected] (P.B.); [email protected] (N.N.); [email protected] (N.P.-Š.) 2 Department of Biology, School of Medicine, University of Zagreb, Šalata 3, 10 000 Zagreb, Croatia 3 Department of Pathology, School of Medicine, University of Zagreb, Šalata 10, 10 000 Zagreb, Croatia; [email protected] 4 Division of Pathology, University Hospital Center “Zagreb”, Kišpati´ceva12, 10 000 Zagreb, Croatia 5 Department of Neurosurgery, University Hospital Center “Zagreb”, School of Medicine, University of Zagreb, Kišpati´ceva12, 10 000 Zagreb, Croatia * Correspondence: [email protected] Simple Summary: Astrocytomas are the most common type of primary brain tumor in adults. In this study, 64 astrocytoma samples of grades II–IV were analyzed for genetic and epigenetic changes as Citation: Kafka, A.; Bukovac, A.; well as protein expression patterns in order to explore the roles of the Wnt pathway components, such Brglez, E.; Jarmek, A.-M.; Poljak, K.; Brlek, P.; Žarkovi´c,K.; Njiri´c,N.; as DKK1, DKK3, GSK3β, β-catenin, and APC in astrocytoma initiation and progression.
    [Show full text]
  • Dickkopf-3 in Human Malignant Tumours: a Clinical Viewpoint EUN-JU LEE 1, QUE THANH THANH NGUYEN 1 and MOOYUL LEE 2
    ANTICANCER RESEARCH 40 : 5969-5979 (2020) doi:10.21873/anticanres.14617 Review Dickkopf-3 in Human Malignant Tumours: A Clinical Viewpoint EUN-JU LEE 1, QUE THANH THANH NGUYEN 1 and MOOYUL LEE 2 1Department of Obstetrics and Gynecology and 2Departement of Physiology, Chung-Ang University School of Medicine, Seoul, Republic of Korea Abstract. Dickkopf-3 (DKK3), also known as REIC, is a According to its sequence homology, DKK3 belongs to the secreted glycoprotein. DKK3 is aberrantly expressed in DKK family of proteins, which consists of DKK1 -4, secreted various types of human malignant tumours. Promoter glycoproteins with two cysteine-rich domains, and Soggy (2, methylation status, intracellular protein expression, and 3). DKK1, -2, and -4 negatively regulate the Wnt signalling protein expression in tumour vessels are significantly pathway by directly interacting with Wnt coreceptors (3, 4), correlated with clinical prognostic factors, including however, the role of DKK3 in Wnt signalling is not clear. It survival. In malignant cells, DKK3 is involved in the has been shown that DKK3 is associated with β- catenin and induction of apoptosis, inhibition of invasion, and c-Jun N-terminal kinase (JNK)-dependent signalling, the remodelling of tumour vasculature. These activities are pathway critical for the progression of cancer. Furthermore, carried out via the regulation of the beta-catenin signalling the tumour-suppressive activities of DKK3 have been and c-Jun N-terminal kinase-dependent cellular pathway, demonstrated in a variety of cancers. both of which are critical for carcinogenesis. This review In the present review, we summarize the clinical explores the potential value of DKK3 as a clinical biomarker significance, cellular functions, and intracellular signalling and a therapeutic candidate in human malignancies.
    [Show full text]
  • Regulation of Dkk1, an Inhibitor of the Wnt Signaling Pathway, by DAX-1 in Mouse Embryonic Stem Cells Victor D
    The University of San Francisco USF Scholarship: a digital repository @ Gleeson Library | Geschke Center Undergraduate Honors Theses Theses, Dissertations, Capstones and Projects Winter 12-14-2014 Regulation of Dkk1, an Inhibitor of the Wnt Signaling Pathway, by DAX-1 in Mouse Embryonic Stem Cells Victor D. Gavallos University of San Francisco, [email protected] Follow this and additional works at: http://repository.usfca.edu/honors Part of the Cellular and Molecular Physiology Commons Recommended Citation Gavallos, Victor D., "Regulation of Dkk1, an Inhibitor of the Wnt Signaling Pathway, by DAX-1 in Mouse Embryonic Stem Cells" (2014). Undergraduate Honors Theses. Paper 4. This Honors Thesis is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. It has been accepted for inclusion in Undergraduate Honors Theses by an authorized administrator of USF Scholarship: a digital repository @ Gleeson Library | Geschke Center. For more information, please contact [email protected]. 1 Abstract DAX-1 is known to play a key role in the maintenance of pluripotency in mouse embryonic stem cells (mESC), such that elimination of DAX-1 (through methods such as RNAi) leads to the differentiation of ESC (Khalfallah et al. 2009). Earlier research by the Tzagarakis-Foster lab identified target genes of DAX-1 in mESC through PCR array methodology (Torres 2013). The Dickkopf 1 gene (Dkk1) was identified as a potential target of DAX-1 by these studies and has since been confirmed to be a DAX-1 target in mESC. However, to date very little is understood of the mechanism of DAX-1 repression of Dkk1 in mESC.
    [Show full text]